Transcatheter treatment option addresses an unmet need

“Today, TAVI allows patients who are at very high surgical risk or with contraindications to surgical AVR to benefit from an effective treatment of AS.”
–D. Himbert, Bichat Hospital, Paris1

Transcatheter aortic valve implantation

Aortic Stenosis New Treatment Options

A new option for patients with severe AS considered to be high risk for surgical AVR is transcatheter aortic valve implantation, or TAVI. In this procedure, the valve is delivered via transfemoral, transapical or transaortic access without open-heart surgery. The Edwards SAPIEN valve received the CE mark in 2007.

Download aortic stenosis brochure

  1. Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009; 54:303-11.

Any quotes used in this material are taken from independent third-party publications and are not intended to imply that such third party reviewed or endorsed any of the products of Edwards Lifesciences.

For professional use

For professional use

See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse event.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Please update your browser

Please update to a current version of your preferred browser, this site will perform effectively on the following:

Unable to update your browser?

If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility